4//SEC Filing
Silberstein Charles 4
Accession 0001209191-21-070085
CIK 0001697532other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 8:28 PM ET
Size
7.8 KB
Accession
0001209191-21-070085
Insider Transaction Report
Form 4
Silberstein Charles
Chief Financial Officer
Transactions
- Award
Common Stock
2021-12-14+47,900→ 135,703 total - Award
Employee Stock Option (Right to Buy)
2021-12-14+32,000→ 32,000 totalExercise: $9.44Exp: 2031-12-14→ Common Stock (32,000 underlying)
Footnotes (2)
- [F1]Consists of compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on each of December 14, 2022, December 14, 2023, December 14, 2024 and December 14, 2025, subject to the Reporting Person continuing to provide services through each such date.
- [F2]Consists of compensatory options granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. One-fourth (1/4th) of the shares subject to the compensatory Option shall vest on December 14, 2022, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Option shall vest each month thereafter, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001813117
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 8:28 PM ET
- Size
- 7.8 KB